Skip to main content
. Author manuscript; available in PMC: 2022 Mar 12.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2021 Jul 4;21(11):e895–e902. doi: 10.1016/j.clml.2021.06.022

Table 3:

Therapy Results

Responses N=137 %

Complete Remission (CR) 96 70
CR / Incomplete count recovery (CRi) 21 15
 Minimal Residual Disease Negative at CR 69 59
Primary Refractory 19 14
Early Death (< 4 weeks) 1 1